nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Haemoglobin—Doxorubicin—stomach cancer	0.000656	0.000656	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000655	0.000655	CcSEcCtD
Gadoversetamide—Flushing—Epirubicin—stomach cancer	0.000655	0.000655	CcSEcCtD
Gadoversetamide—Cardiac disorder—Epirubicin—stomach cancer	0.000655	0.000655	CcSEcCtD
Gadoversetamide—Vomiting—Fluorouracil—stomach cancer	0.000654	0.000654	CcSEcCtD
Gadoversetamide—Rhinitis—Doxorubicin—stomach cancer	0.000654	0.000654	CcSEcCtD
Gadoversetamide—Dyspepsia—Docetaxel—stomach cancer	0.000654	0.000654	CcSEcCtD
Gadoversetamide—Haemorrhage—Doxorubicin—stomach cancer	0.000653	0.000653	CcSEcCtD
Gadoversetamide—Insomnia—Capecitabine—stomach cancer	0.000651	0.000651	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Doxorubicin—stomach cancer	0.000649	0.000649	CcSEcCtD
Gadoversetamide—Rash—Fluorouracil—stomach cancer	0.000649	0.000649	CcSEcCtD
Gadoversetamide—Dermatitis—Fluorouracil—stomach cancer	0.000648	0.000648	CcSEcCtD
Gadoversetamide—Pharyngitis—Doxorubicin—stomach cancer	0.000648	0.000648	CcSEcCtD
Gadoversetamide—Paraesthesia—Capecitabine—stomach cancer	0.000646	0.000646	CcSEcCtD
Gadoversetamide—Decreased appetite—Docetaxel—stomach cancer	0.000646	0.000646	CcSEcCtD
Gadoversetamide—Headache—Fluorouracil—stomach cancer	0.000645	0.000645	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Doxorubicin—stomach cancer	0.000644	0.000644	CcSEcCtD
Gadoversetamide—Oedema peripheral—Doxorubicin—stomach cancer	0.000643	0.000643	CcSEcCtD
Gadoversetamide—Dysgeusia—Methotrexate—stomach cancer	0.000642	0.000642	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000641	0.000641	CcSEcCtD
Gadoversetamide—Dyspnoea—Capecitabine—stomach cancer	0.000641	0.000641	CcSEcCtD
Gadoversetamide—Fatigue—Docetaxel—stomach cancer	0.00064	0.00064	CcSEcCtD
Gadoversetamide—Angiopathy—Epirubicin—stomach cancer	0.00064	0.00064	CcSEcCtD
Gadoversetamide—Urethral disorder—Doxorubicin—stomach cancer	0.00064	0.00064	CcSEcCtD
Gadoversetamide—Nausea—Irinotecan—stomach cancer	0.000638	0.000638	CcSEcCtD
Gadoversetamide—Immune system disorder—Epirubicin—stomach cancer	0.000637	0.000637	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Epirubicin—stomach cancer	0.000636	0.000636	CcSEcCtD
Gadoversetamide—Constipation—Docetaxel—stomach cancer	0.000635	0.000635	CcSEcCtD
Gadoversetamide—Pain—Docetaxel—stomach cancer	0.000635	0.000635	CcSEcCtD
Gadoversetamide—Back pain—Methotrexate—stomach cancer	0.000635	0.000635	CcSEcCtD
Gadoversetamide—Dyspepsia—Capecitabine—stomach cancer	0.000633	0.000633	CcSEcCtD
Gadoversetamide—Chills—Epirubicin—stomach cancer	0.000633	0.000633	CcSEcCtD
Gadoversetamide—Arrhythmia—Epirubicin—stomach cancer	0.00063	0.00063	CcSEcCtD
Gadoversetamide—Decreased appetite—Capecitabine—stomach cancer	0.000625	0.000625	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000621	0.000621	CcSEcCtD
Gadoversetamide—Fatigue—Capecitabine—stomach cancer	0.00062	0.00062	CcSEcCtD
Gadoversetamide—Vision blurred—Methotrexate—stomach cancer	0.000618	0.000618	CcSEcCtD
Gadoversetamide—Mental disorder—Epirubicin—stomach cancer	0.000618	0.000618	CcSEcCtD
Gadoversetamide—Erythema multiforme—Doxorubicin—stomach cancer	0.000617	0.000617	CcSEcCtD
Gadoversetamide—Pain—Capecitabine—stomach cancer	0.000615	0.000615	CcSEcCtD
Gadoversetamide—Constipation—Capecitabine—stomach cancer	0.000615	0.000615	CcSEcCtD
Gadoversetamide—Malnutrition—Epirubicin—stomach cancer	0.000614	0.000614	CcSEcCtD
Gadoversetamide—Erythema—Epirubicin—stomach cancer	0.000614	0.000614	CcSEcCtD
Gadoversetamide—Feeling abnormal—Docetaxel—stomach cancer	0.000612	0.000612	CcSEcCtD
Gadoversetamide—Nausea—Fluorouracil—stomach cancer	0.000611	0.000611	CcSEcCtD
Gadoversetamide—Eye disorder—Doxorubicin—stomach cancer	0.00061	0.00061	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Methotrexate—stomach cancer	0.000609	0.000609	CcSEcCtD
Gadoversetamide—Tinnitus—Doxorubicin—stomach cancer	0.000608	0.000608	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Docetaxel—stomach cancer	0.000607	0.000607	CcSEcCtD
Gadoversetamide—Flushing—Doxorubicin—stomach cancer	0.000606	0.000606	CcSEcCtD
Gadoversetamide—Cardiac disorder—Doxorubicin—stomach cancer	0.000606	0.000606	CcSEcCtD
Gadoversetamide—Flatulence—Epirubicin—stomach cancer	0.000605	0.000605	CcSEcCtD
Gadoversetamide—Tension—Epirubicin—stomach cancer	0.000602	0.000602	CcSEcCtD
Gadoversetamide—Dysgeusia—Epirubicin—stomach cancer	0.000601	0.000601	CcSEcCtD
Gadoversetamide—Nervousness—Epirubicin—stomach cancer	0.000596	0.000596	CcSEcCtD
Gadoversetamide—Back pain—Epirubicin—stomach cancer	0.000594	0.000594	CcSEcCtD
Gadoversetamide—Feeling abnormal—Capecitabine—stomach cancer	0.000593	0.000593	CcSEcCtD
Gadoversetamide—Angiopathy—Doxorubicin—stomach cancer	0.000592	0.000592	CcSEcCtD
Gadoversetamide—Malaise—Methotrexate—stomach cancer	0.000592	0.000592	CcSEcCtD
Gadoversetamide—Muscle spasms—Epirubicin—stomach cancer	0.00059	0.00059	CcSEcCtD
Gadoversetamide—Immune system disorder—Doxorubicin—stomach cancer	0.000589	0.000589	CcSEcCtD
Gadoversetamide—Vertigo—Methotrexate—stomach cancer	0.000589	0.000589	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Capecitabine—stomach cancer	0.000588	0.000588	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Doxorubicin—stomach cancer	0.000588	0.000588	CcSEcCtD
Gadoversetamide—Abdominal pain—Docetaxel—stomach cancer	0.000587	0.000587	CcSEcCtD
Gadoversetamide—Body temperature increased—Docetaxel—stomach cancer	0.000587	0.000587	CcSEcCtD
Gadoversetamide—Chills—Doxorubicin—stomach cancer	0.000586	0.000586	CcSEcCtD
Gadoversetamide—Arrhythmia—Doxorubicin—stomach cancer	0.000583	0.000583	CcSEcCtD
Gadoversetamide—Vision blurred—Epirubicin—stomach cancer	0.000579	0.000579	CcSEcCtD
Gadoversetamide—Cough—Methotrexate—stomach cancer	0.000572	0.000572	CcSEcCtD
Gadoversetamide—Mental disorder—Doxorubicin—stomach cancer	0.000572	0.000572	CcSEcCtD
Gadoversetamide—Urticaria—Capecitabine—stomach cancer	0.000571	0.000571	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Epirubicin—stomach cancer	0.00057	0.00057	CcSEcCtD
Gadoversetamide—Abdominal pain—Capecitabine—stomach cancer	0.000569	0.000569	CcSEcCtD
Gadoversetamide—Body temperature increased—Capecitabine—stomach cancer	0.000569	0.000569	CcSEcCtD
Gadoversetamide—Convulsion—Methotrexate—stomach cancer	0.000568	0.000568	CcSEcCtD
Gadoversetamide—Erythema—Doxorubicin—stomach cancer	0.000568	0.000568	CcSEcCtD
Gadoversetamide—Malnutrition—Doxorubicin—stomach cancer	0.000568	0.000568	CcSEcCtD
Gadoversetamide—Agitation—Epirubicin—stomach cancer	0.000564	0.000564	CcSEcCtD
Gadoversetamide—Flatulence—Doxorubicin—stomach cancer	0.00056	0.00056	CcSEcCtD
Gadoversetamide—Chest pain—Methotrexate—stomach cancer	0.000559	0.000559	CcSEcCtD
Gadoversetamide—Arthralgia—Methotrexate—stomach cancer	0.000559	0.000559	CcSEcCtD
Gadoversetamide—Myalgia—Methotrexate—stomach cancer	0.000559	0.000559	CcSEcCtD
Gadoversetamide—Tension—Doxorubicin—stomach cancer	0.000557	0.000557	CcSEcCtD
Gadoversetamide—Dysgeusia—Doxorubicin—stomach cancer	0.000556	0.000556	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000555	0.000555	CcSEcCtD
Gadoversetamide—Malaise—Epirubicin—stomach cancer	0.000554	0.000554	CcSEcCtD
Gadoversetamide—Discomfort—Methotrexate—stomach cancer	0.000552	0.000552	CcSEcCtD
Gadoversetamide—Nervousness—Doxorubicin—stomach cancer	0.000552	0.000552	CcSEcCtD
Gadoversetamide—Vertigo—Epirubicin—stomach cancer	0.000552	0.000552	CcSEcCtD
Gadoversetamide—Syncope—Epirubicin—stomach cancer	0.000551	0.000551	CcSEcCtD
Gadoversetamide—Back pain—Doxorubicin—stomach cancer	0.000549	0.000549	CcSEcCtD
Gadoversetamide—Hypersensitivity—Docetaxel—stomach cancer	0.000547	0.000547	CcSEcCtD
Gadoversetamide—Muscle spasms—Doxorubicin—stomach cancer	0.000546	0.000546	CcSEcCtD
Gadoversetamide—Palpitations—Epirubicin—stomach cancer	0.000543	0.000543	CcSEcCtD
Gadoversetamide—Confusional state—Methotrexate—stomach cancer	0.00054	0.00054	CcSEcCtD
Gadoversetamide—Loss of consciousness—Epirubicin—stomach cancer	0.00054	0.00054	CcSEcCtD
Gadoversetamide—Cough—Epirubicin—stomach cancer	0.000536	0.000536	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Methotrexate—stomach cancer	0.000535	0.000535	CcSEcCtD
Gadoversetamide—Vision blurred—Doxorubicin—stomach cancer	0.000535	0.000535	CcSEcCtD
Gadoversetamide—Asthenia—Docetaxel—stomach cancer	0.000533	0.000533	CcSEcCtD
Gadoversetamide—Convulsion—Epirubicin—stomach cancer	0.000532	0.000532	CcSEcCtD
Gadoversetamide—Hypertension—Epirubicin—stomach cancer	0.00053	0.00053	CcSEcCtD
Gadoversetamide—Hypersensitivity—Capecitabine—stomach cancer	0.00053	0.00053	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Doxorubicin—stomach cancer	0.000527	0.000527	CcSEcCtD
Gadoversetamide—Pruritus—Docetaxel—stomach cancer	0.000526	0.000526	CcSEcCtD
Gadoversetamide—Nervous system disorder—Methotrexate—stomach cancer	0.000525	0.000525	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Methotrexate—stomach cancer	0.000524	0.000524	CcSEcCtD
Gadoversetamide—Chest pain—Epirubicin—stomach cancer	0.000523	0.000523	CcSEcCtD
Gadoversetamide—Arthralgia—Epirubicin—stomach cancer	0.000523	0.000523	CcSEcCtD
Gadoversetamide—Myalgia—Epirubicin—stomach cancer	0.000523	0.000523	CcSEcCtD
Gadoversetamide—Agitation—Doxorubicin—stomach cancer	0.000522	0.000522	CcSEcCtD
Gadoversetamide—Anxiety—Epirubicin—stomach cancer	0.000521	0.000521	CcSEcCtD
Gadoversetamide—Skin disorder—Methotrexate—stomach cancer	0.00052	0.00052	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000519	0.000519	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Methotrexate—stomach cancer	0.000518	0.000518	CcSEcCtD
Gadoversetamide—Discomfort—Epirubicin—stomach cancer	0.000516	0.000516	CcSEcCtD
Gadoversetamide—Asthenia—Capecitabine—stomach cancer	0.000516	0.000516	CcSEcCtD
Gadoversetamide—Malaise—Doxorubicin—stomach cancer	0.000512	0.000512	CcSEcCtD
Gadoversetamide—Dry mouth—Epirubicin—stomach cancer	0.000511	0.000511	CcSEcCtD
Gadoversetamide—Vertigo—Doxorubicin—stomach cancer	0.00051	0.00051	CcSEcCtD
Gadoversetamide—Anorexia—Methotrexate—stomach cancer	0.00051	0.00051	CcSEcCtD
Gadoversetamide—Syncope—Doxorubicin—stomach cancer	0.000509	0.000509	CcSEcCtD
Gadoversetamide—Pruritus—Capecitabine—stomach cancer	0.000509	0.000509	CcSEcCtD
Gadoversetamide—Diarrhoea—Docetaxel—stomach cancer	0.000508	0.000508	CcSEcCtD
Gadoversetamide—Confusional state—Epirubicin—stomach cancer	0.000505	0.000505	CcSEcCtD
Gadoversetamide—Palpitations—Doxorubicin—stomach cancer	0.000502	0.000502	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Epirubicin—stomach cancer	0.000501	0.000501	CcSEcCtD
Gadoversetamide—Oedema—Epirubicin—stomach cancer	0.000501	0.000501	CcSEcCtD
Gadoversetamide—Hypotension—Methotrexate—stomach cancer	0.0005	0.0005	CcSEcCtD
Gadoversetamide—Loss of consciousness—Doxorubicin—stomach cancer	0.000499	0.000499	CcSEcCtD
Gadoversetamide—Cough—Doxorubicin—stomach cancer	0.000496	0.000496	CcSEcCtD
Gadoversetamide—Shock—Epirubicin—stomach cancer	0.000493	0.000493	CcSEcCtD
Gadoversetamide—Convulsion—Doxorubicin—stomach cancer	0.000492	0.000492	CcSEcCtD
Gadoversetamide—Diarrhoea—Capecitabine—stomach cancer	0.000492	0.000492	CcSEcCtD
Gadoversetamide—Nervous system disorder—Epirubicin—stomach cancer	0.000491	0.000491	CcSEcCtD
Gadoversetamide—Dizziness—Docetaxel—stomach cancer	0.000491	0.000491	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Epirubicin—stomach cancer	0.000491	0.000491	CcSEcCtD
Gadoversetamide—Hypertension—Doxorubicin—stomach cancer	0.00049	0.00049	CcSEcCtD
Gadoversetamide—Tachycardia—Epirubicin—stomach cancer	0.000489	0.000489	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000488	0.000488	CcSEcCtD
Gadoversetamide—Skin disorder—Epirubicin—stomach cancer	0.000487	0.000487	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Epirubicin—stomach cancer	0.000484	0.000484	CcSEcCtD
Gadoversetamide—Insomnia—Methotrexate—stomach cancer	0.000484	0.000484	CcSEcCtD
Gadoversetamide—Chest pain—Doxorubicin—stomach cancer	0.000484	0.000484	CcSEcCtD
Gadoversetamide—Arthralgia—Doxorubicin—stomach cancer	0.000484	0.000484	CcSEcCtD
Gadoversetamide—Myalgia—Doxorubicin—stomach cancer	0.000484	0.000484	CcSEcCtD
Gadoversetamide—Anxiety—Doxorubicin—stomach cancer	0.000482	0.000482	CcSEcCtD
Gadoversetamide—Paraesthesia—Methotrexate—stomach cancer	0.000481	0.000481	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00048	0.00048	CcSEcCtD
Gadoversetamide—Discomfort—Doxorubicin—stomach cancer	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Anorexia—Epirubicin—stomach cancer	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Dyspnoea—Methotrexate—stomach cancer	0.000477	0.000477	CcSEcCtD
Gadoversetamide—Somnolence—Methotrexate—stomach cancer	0.000476	0.000476	CcSEcCtD
Gadoversetamide—Dizziness—Capecitabine—stomach cancer	0.000476	0.000476	CcSEcCtD
Gadoversetamide—Dry mouth—Doxorubicin—stomach cancer	0.000473	0.000473	CcSEcCtD
Gadoversetamide—Vomiting—Docetaxel—stomach cancer	0.000472	0.000472	CcSEcCtD
Gadoversetamide—Dyspepsia—Methotrexate—stomach cancer	0.000471	0.000471	CcSEcCtD
Gadoversetamide—Rash—Docetaxel—stomach cancer	0.000468	0.000468	CcSEcCtD
Gadoversetamide—Hypotension—Epirubicin—stomach cancer	0.000468	0.000468	CcSEcCtD
Gadoversetamide—Dermatitis—Docetaxel—stomach cancer	0.000468	0.000468	CcSEcCtD
Gadoversetamide—Confusional state—Doxorubicin—stomach cancer	0.000467	0.000467	CcSEcCtD
Gadoversetamide—Decreased appetite—Methotrexate—stomach cancer	0.000465	0.000465	CcSEcCtD
Gadoversetamide—Headache—Docetaxel—stomach cancer	0.000465	0.000465	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Doxorubicin—stomach cancer	0.000464	0.000464	CcSEcCtD
Gadoversetamide—Oedema—Doxorubicin—stomach cancer	0.000464	0.000464	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Fatigue—Methotrexate—stomach cancer	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Pain—Methotrexate—stomach cancer	0.000458	0.000458	CcSEcCtD
Gadoversetamide—Vomiting—Capecitabine—stomach cancer	0.000457	0.000457	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000457	0.000457	CcSEcCtD
Gadoversetamide—Shock—Doxorubicin—stomach cancer	0.000456	0.000456	CcSEcCtD
Gadoversetamide—Nervous system disorder—Doxorubicin—stomach cancer	0.000455	0.000455	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Doxorubicin—stomach cancer	0.000454	0.000454	CcSEcCtD
Gadoversetamide—Rash—Capecitabine—stomach cancer	0.000454	0.000454	CcSEcCtD
Gadoversetamide—Insomnia—Epirubicin—stomach cancer	0.000453	0.000453	CcSEcCtD
Gadoversetamide—Dermatitis—Capecitabine—stomach cancer	0.000453	0.000453	CcSEcCtD
Gadoversetamide—Tachycardia—Doxorubicin—stomach cancer	0.000452	0.000452	CcSEcCtD
Gadoversetamide—Headache—Capecitabine—stomach cancer	0.000451	0.000451	CcSEcCtD
Gadoversetamide—Skin disorder—Doxorubicin—stomach cancer	0.00045	0.00045	CcSEcCtD
Gadoversetamide—Paraesthesia—Epirubicin—stomach cancer	0.00045	0.00045	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Doxorubicin—stomach cancer	0.000448	0.000448	CcSEcCtD
Gadoversetamide—Dyspnoea—Epirubicin—stomach cancer	0.000447	0.000447	CcSEcCtD
Gadoversetamide—Somnolence—Epirubicin—stomach cancer	0.000445	0.000445	CcSEcCtD
Gadoversetamide—Anorexia—Doxorubicin—stomach cancer	0.000442	0.000442	CcSEcCtD
Gadoversetamide—Nausea—Docetaxel—stomach cancer	0.000441	0.000441	CcSEcCtD
Gadoversetamide—Feeling abnormal—Methotrexate—stomach cancer	0.000441	0.000441	CcSEcCtD
Gadoversetamide—Dyspepsia—Epirubicin—stomach cancer	0.000441	0.000441	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Methotrexate—stomach cancer	0.000438	0.000438	CcSEcCtD
Gadoversetamide—Decreased appetite—Epirubicin—stomach cancer	0.000436	0.000436	CcSEcCtD
Gadoversetamide—Hypotension—Doxorubicin—stomach cancer	0.000433	0.000433	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000433	0.000433	CcSEcCtD
Gadoversetamide—Fatigue—Epirubicin—stomach cancer	0.000432	0.000432	CcSEcCtD
Gadoversetamide—Pain—Epirubicin—stomach cancer	0.000428	0.000428	CcSEcCtD
Gadoversetamide—Constipation—Epirubicin—stomach cancer	0.000428	0.000428	CcSEcCtD
Gadoversetamide—Nausea—Capecitabine—stomach cancer	0.000427	0.000427	CcSEcCtD
Gadoversetamide—Urticaria—Methotrexate—stomach cancer	0.000425	0.000425	CcSEcCtD
Gadoversetamide—Abdominal pain—Methotrexate—stomach cancer	0.000423	0.000423	CcSEcCtD
Gadoversetamide—Body temperature increased—Methotrexate—stomach cancer	0.000423	0.000423	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000422	0.000422	CcSEcCtD
Gadoversetamide—Insomnia—Doxorubicin—stomach cancer	0.000419	0.000419	CcSEcCtD
Gadoversetamide—Paraesthesia—Doxorubicin—stomach cancer	0.000416	0.000416	CcSEcCtD
Gadoversetamide—Dyspnoea—Doxorubicin—stomach cancer	0.000413	0.000413	CcSEcCtD
Gadoversetamide—Feeling abnormal—Epirubicin—stomach cancer	0.000413	0.000413	CcSEcCtD
Gadoversetamide—Somnolence—Doxorubicin—stomach cancer	0.000412	0.000412	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Epirubicin—stomach cancer	0.00041	0.00041	CcSEcCtD
Gadoversetamide—Dyspepsia—Doxorubicin—stomach cancer	0.000408	0.000408	CcSEcCtD
Gadoversetamide—Decreased appetite—Doxorubicin—stomach cancer	0.000403	0.000403	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.0004	0.0004	CcSEcCtD
Gadoversetamide—Fatigue—Doxorubicin—stomach cancer	0.0004	0.0004	CcSEcCtD
Gadoversetamide—Urticaria—Epirubicin—stomach cancer	0.000398	0.000398	CcSEcCtD
Gadoversetamide—Pain—Doxorubicin—stomach cancer	0.000396	0.000396	CcSEcCtD
Gadoversetamide—Constipation—Doxorubicin—stomach cancer	0.000396	0.000396	CcSEcCtD
Gadoversetamide—Body temperature increased—Epirubicin—stomach cancer	0.000396	0.000396	CcSEcCtD
Gadoversetamide—Abdominal pain—Epirubicin—stomach cancer	0.000396	0.000396	CcSEcCtD
Gadoversetamide—Hypersensitivity—Methotrexate—stomach cancer	0.000394	0.000394	CcSEcCtD
Gadoversetamide—Asthenia—Methotrexate—stomach cancer	0.000384	0.000384	CcSEcCtD
Gadoversetamide—Feeling abnormal—Doxorubicin—stomach cancer	0.000382	0.000382	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000379	0.000379	CcSEcCtD
Gadoversetamide—Pruritus—Methotrexate—stomach cancer	0.000379	0.000379	CcSEcCtD
Gadoversetamide—Hypersensitivity—Epirubicin—stomach cancer	0.000369	0.000369	CcSEcCtD
Gadoversetamide—Urticaria—Doxorubicin—stomach cancer	0.000368	0.000368	CcSEcCtD
Gadoversetamide—Body temperature increased—Doxorubicin—stomach cancer	0.000367	0.000367	CcSEcCtD
Gadoversetamide—Abdominal pain—Doxorubicin—stomach cancer	0.000367	0.000367	CcSEcCtD
Gadoversetamide—Diarrhoea—Methotrexate—stomach cancer	0.000366	0.000366	CcSEcCtD
Gadoversetamide—Asthenia—Epirubicin—stomach cancer	0.00036	0.00036	CcSEcCtD
Gadoversetamide—Pruritus—Epirubicin—stomach cancer	0.000355	0.000355	CcSEcCtD
Gadoversetamide—Dizziness—Methotrexate—stomach cancer	0.000354	0.000354	CcSEcCtD
Gadoversetamide—Diarrhoea—Epirubicin—stomach cancer	0.000343	0.000343	CcSEcCtD
Gadoversetamide—Hypersensitivity—Doxorubicin—stomach cancer	0.000342	0.000342	CcSEcCtD
Gadoversetamide—Vomiting—Methotrexate—stomach cancer	0.00034	0.00034	CcSEcCtD
Gadoversetamide—Rash—Methotrexate—stomach cancer	0.000338	0.000338	CcSEcCtD
Gadoversetamide—Dermatitis—Methotrexate—stomach cancer	0.000337	0.000337	CcSEcCtD
Gadoversetamide—Headache—Methotrexate—stomach cancer	0.000335	0.000335	CcSEcCtD
Gadoversetamide—Asthenia—Doxorubicin—stomach cancer	0.000333	0.000333	CcSEcCtD
Gadoversetamide—Dizziness—Epirubicin—stomach cancer	0.000331	0.000331	CcSEcCtD
Gadoversetamide—Pruritus—Doxorubicin—stomach cancer	0.000328	0.000328	CcSEcCtD
Gadoversetamide—Vomiting—Epirubicin—stomach cancer	0.000319	0.000319	CcSEcCtD
Gadoversetamide—Nausea—Methotrexate—stomach cancer	0.000318	0.000318	CcSEcCtD
Gadoversetamide—Diarrhoea—Doxorubicin—stomach cancer	0.000317	0.000317	CcSEcCtD
Gadoversetamide—Rash—Epirubicin—stomach cancer	0.000316	0.000316	CcSEcCtD
Gadoversetamide—Dermatitis—Epirubicin—stomach cancer	0.000316	0.000316	CcSEcCtD
Gadoversetamide—Headache—Epirubicin—stomach cancer	0.000314	0.000314	CcSEcCtD
Gadoversetamide—Dizziness—Doxorubicin—stomach cancer	0.000307	0.000307	CcSEcCtD
Gadoversetamide—Nausea—Epirubicin—stomach cancer	0.000298	0.000298	CcSEcCtD
Gadoversetamide—Vomiting—Doxorubicin—stomach cancer	0.000295	0.000295	CcSEcCtD
Gadoversetamide—Rash—Doxorubicin—stomach cancer	0.000292	0.000292	CcSEcCtD
Gadoversetamide—Dermatitis—Doxorubicin—stomach cancer	0.000292	0.000292	CcSEcCtD
Gadoversetamide—Headache—Doxorubicin—stomach cancer	0.00029	0.00029	CcSEcCtD
Gadoversetamide—Nausea—Doxorubicin—stomach cancer	0.000275	0.000275	CcSEcCtD
